Ovarian cancer test accuracy under review

NCT ID NCT07539844

Not yet recruiting Knowledge-focused Sponsor: AbbVie Source: ClinicalTrials.gov ↗

First seen Apr 26, 2026 · Last updated May 12, 2026 · Updated 3 times

Summary

This study looks at how well different labs agree when testing for a protein called FRa in stored tissue samples from people with ovarian cancer. About 1,000 women will have their old biopsy samples tested again. No new treatments or visits are needed. The goal is to improve future testing consistency.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.